| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M406639200 |
| P698 | PubMed publication ID | 15277520 |
| P50 | author | Philip C. Trackman | Q40642250 |
| Sebastien Jeay | Q73078896 | ||
| P2093 | author name string | Ying Guo | |
| Amitha H Palamakumbura | |||
| Gail E Sonenshein | |||
| Nicole Pischon | |||
| Pascal Sommer | |||
| P2860 | cites work | A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity | Q26778490 |
| A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
| Bone morphogenetic protein-1: the type I procollagen C-proteinase | Q28115746 | ||
| Gene switching by metabolic enzymes--how did you get on the invitation list? | Q28190497 | ||
| S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component | Q28190509 | ||
| Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell | Q28208372 | ||
| The activation of phosphatidylinositol 3-kinase by Ras | Q28305326 | ||
| Fully processed lysyl oxidase catalyst translocates from the extracellular space into nuclei of aortic smooth-muscle cells | Q28568824 | ||
| 35 Lysyl oxidase: Preparation and role in elastin biosynthesis | Q28610079 | ||
| Metalloproteinase Activity Secreted by Fibrogenic Cells in the Processing of Prolysyl Oxidase | Q29544584 | ||
| Recruitment of enzymes as lens structural proteins | Q30473651 | ||
| Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine | Q33216759 | ||
| Cloning of rat aorta lysyl oxidase cDNA: complete codons and predicted amino acid sequence | Q33500041 | ||
| Ribosomal DNA: Molecular Evolution and Phylogenetic Inference | Q33845314 | ||
| Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures | Q33943363 | ||
| Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus | Q34253429 | ||
| The role of collagen-derived proteolytic fragments in angiogenesis | Q34375953 | ||
| A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples | Q34520249 | ||
| Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B. | Q34784159 | ||
| Heparan sulfate proteoglycan as a plasma membrane carrier | Q35084374 | ||
| Suramin inhibits wound healing following filtering procedures for glaucoma | Q35306077 | ||
| Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. | Q36288339 | ||
| Properties and Function of Lysyl Oxidase | Q36520735 | ||
| Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine | Q36842359 | ||
| Suramin, a novel antitumor compound. | Q38031515 | ||
| A role for lysyl oxidase regulation in the control of normal collagen deposition in differentiating osteoblast cultures | Q40557286 | ||
| Autocrine growth factor regulation of lysyl oxidase expression in transformed fibroblasts | Q40642135 | ||
| Down-regulation of lysyl oxidase-induced tumorigenic transformation in NRK-49F cells characterized by constitutive activation of ras proto-oncogene | Q40809856 | ||
| Trimer carboxyl propeptide of collagen I produced by mature osteoblasts is chemotactic for endothelial cells | Q40864506 | ||
| The osteoblastic MC3T3-E1 cells synthesized C-terminal propeptide of type I collagen, which promoted cell-attachment of osteoblasts | Q41134762 | ||
| Quantitative polymerase chain reaction of lysyl oxidase mRNA in malignantly transformed human cell lines demonstrates that their low lysyl oxidase activity is due to low quantities of its mRNA and low levels of transcription of the respective gene. | Q41295028 | ||
| Lysyl oxidase and rrg messenger RNA. | Q41669222 | ||
| Expression of Gene rrg Is Associated with Reversion of NIH 3Tt3 Transformed by LTR-c-H- ras | Q41724661 | ||
| Suramin in adrenal cancer: modulation of steroid hormone production, cytotoxicity in vitro, and clinical antitumor effect. | Q41725624 | ||
| Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone | Q41726848 | ||
| Pre- and post-translational regulation of lysyl oxidase by transforming growth factor-beta 1 in osteoblastic MC3T3-E1 cells | Q42818962 | ||
| The effect of carboxyl-terminal propeptide of type I collagen (c-propeptide) on collagen synthesis of preosteoblasts and osteoblasts | Q42832951 | ||
| Deficient production of lysyl oxidase in cultures of malignantly transformed human cells. | Q53538666 | ||
| The Complete Derived Amino Acid Sequence of Human Lysyl Oxidase and Assignment of the Gene to Chromosomes 5 | Q56593724 | ||
| Molecular Characterisation of Integrin-Procollagen C-Propeptide Interactions | Q58058109 | ||
| P433 | issue | 39 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 40593-40600 | |
| P577 | publication date | 2004-07-23 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells | |
| P478 | volume | 279 |
| Q53176750 | A Polymorphism in the Lysyl Oxidase Propeptide Domain Accelerates Carcinogen-induced Cancer. |
| Q37312261 | A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer |
| Q24314451 | A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression |
| Q83920700 | Activation of cellular chemotactic responses to chemokines coupled with oxidation of plasma membrane proteins by lysyl oxidase |
| Q36367333 | Akbu-LAAO exhibits potent anti-tumor activity to HepG2 cells partially through produced H2O2 via TGF-β signal pathway |
| Q34070903 | Association of the G473A polymorphism and expression of lysyl oxidase with breast cancer risk and survival in European women: a hospital-based case-control study |
| Q34206164 | Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide |
| Q42853848 | Characterization of recombinant lysyl oxidase propeptide |
| Q34371559 | Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer. |
| Q38841862 | Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide |
| Q61454345 | Divergent roles of lysyl oxidase family members in ornithine decarboxylase- and RAS-transformed mouse fibroblasts and human melanoma cells |
| Q36259191 | Diverse biological functions of extracellular collagen processing enzymes |
| Q38563638 | EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma. |
| Q90181271 | Effects of High Glucose-Induced Lysyl Oxidase Propeptide on Retinal Endothelial Cell Survival: Implications for Diabetic Retinopathy |
| Q38989588 | Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways |
| Q36923574 | Enzymatic and non-enzymatic functions of the lysyl oxidase family in bone |
| Q47584936 | Functional importance of lysyl oxidase family propeptide regions |
| Q40234158 | Habitual physical activity protects against lipopolysaccharide-induced inflammation in mouse adipose tissue |
| Q35821224 | High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting |
| Q34355294 | High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function |
| Q39376172 | Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway |
| Q30009534 | Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide |
| Q40068242 | Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer |
| Q64905661 | Inhibition of angiogenesis in endothelial cells by Human Lysyl oxidase propeptide. |
| Q58799743 | Insights into the structure and dynamics of lysyl oxidase propeptide, a flexible protein with numerous partners |
| Q40243976 | Intracellular distribution of the lysyl oxidase propeptide in osteoblastic cells |
| Q34303455 | LOXL2 in epithelial cell plasticity and tumor progression |
| Q37707030 | LOXL4 knockdown enhances tumor growth and lung metastasis through collagen-dependent extracellular matrix changes in triple-negative breast cancer |
| Q36404717 | Lysine post-translational modifications of collagen |
| Q51538665 | Lysyl Oxidase 473 G>A Polymorphism and Breast Cancer Susceptibility in Chinese Han Population |
| Q38723997 | Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer |
| Q37631469 | Lysyl Oxidase and the Tumor Microenvironment |
| Q39224283 | Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype. |
| Q42720975 | Lysyl oxidase and enhancement of cell proliferation and angiogenesis in oral squamous cell carcinoma. |
| Q55176262 | Lysyl oxidase family members in urological tumorigenesis and fibrosis. |
| Q38134562 | Lysyl oxidase in colorectal cancer |
| Q34764399 | Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells |
| Q38937873 | Lysyl oxidase isoforms in gastric cancer. |
| Q33748104 | Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts |
| Q39825713 | Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. |
| Q42005506 | Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation |
| Q38815129 | Lysyl oxidase propeptide promotes adipogenesis through inhibition of FGF-2 signaling |
| Q49277335 | Lysyl oxidase propeptide promotes adipogenesis through inhibition of FGF-2 signaling |
| Q37532942 | Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis |
| Q40251892 | Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo |
| Q36126637 | Lysyl oxidase-like-1 enhances lung metastasis when lactate accumulation and monocarboxylate transporter expression are involved |
| Q28587970 | Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation |
| Q37812321 | Lysyl oxidase: a potential target for cancer therapy |
| Q28084024 | Mechanisms involved in breast cancer liver metastasis |
| Q35688339 | Nna1 mediates Purkinje cell dendritic development via lysyl oxidase propeptide and NF-κB signaling |
| Q41694382 | Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients |
| Q34380963 | Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer |
| Q30156005 | Protein Biomarkers for in Vitro Testing of Embryotoxicity |
| Q28236828 | RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis |
| Q34170606 | Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenografts |
| Q34388063 | Retracted: Lysyl Oxidase Polymorphisms and Susceptibility to Osteosarcoma |
| Q37382550 | Role of lysyl oxidase propeptide in secretion and enzyme activity |
| Q34704924 | Silencing of hypoxia-inducible tumor suppressor lysyl oxidase gene by promoter methylation activates carbonic anhydrase IX in nasopharyngeal carcinoma. |
| Q34521147 | Structural ECM components in the premetastatic and metastatic niche |
| Q40434283 | Substrate-specific modulation of a multisubstrate proteinase. C-terminal processing of fibrillar procollagens is the only BMP-1-dependent activity to be enhanced by PCPE-1. |
| Q91823889 | The Extracellular Matrix Modulates the Metastatic Journey |
| Q28510648 | The NH2-terminal propeptide of type I procollagen acts intracellularly to modulate cell function |
| Q24301022 | The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cells |
| Q37041619 | The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells |
| Q24307235 | The lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cells |
| Q38172108 | The potential for targeting extracellular LOX proteins in human malignancy |
| Q38027412 | The rationale for targeting the LOX family in cancer |
| Q35050472 | Transcriptome analysis of PPARγ target genes reveals the involvement of lysyl oxidase in human placental cytotrophoblast invasion |
| Q33292171 | UXT Is a LOX-PP Interacting Protein That Modulates Estrogen Receptor Alpha Activity in Breast Cancer Cells |
| Q37347497 | Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03. |
Search more.